MSDS   | : | p-Benzoquinone,
2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-no
namethyl-2,6,10,14,18,
22,26,30,34-hexatriacontanonaenyl)-
| CAS   | : | 303-97-9 | SYNONYMS   | : | * Coenzyme Q(sub 9)
* CoQ(sub 9)
* Ubiquinone 9
* Ubiquinone 45
* Ubiquinone Q(sub 9)
|
| |
|
|
*** CHEMICAL IDENTIFICATION ***
RTECS NUMBER : DK4786000
CHEMICAL NAME : p-Benzoquinone,
2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-no
namethyl-2,6,10,14,18,
22,26,30,34-hexatriacontanonaenyl)-
CAS REGISTRY NUMBER : 303-97-9
BEILSTEIN REFERENCE NO. : 1900081
REFERENCE : 4-08-00-03313 (Beilstein Handbook Reference)
LAST UPDATED : 199612
DATA ITEMS CITED : 9
MOLECULAR FORMULA : C54-H82-O4
MOLECULAR WEIGHT : 795.36
SYNONYMS/TRADE NAMES :
* Coenzyme Q(sub 9)
* CoQ(sub 9)
* Ubiquinone 9
* Ubiquinone 45
* Ubiquinone Q(sub 9)
*** HEALTH HAZARD DATA ***
** ACUTE TOXICITY DATA **
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >4 gm/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 3,147,1969
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >800 mg/kg
TOXIC EFFECTS :
Behavioral - altered sleep time (including change in righting reflex)
Behavioral - ataxia
Lungs, Thorax, or Respiration - dyspnea
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 3,147,1969
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >600 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 3,147,1969
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >250 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 3,147,1969
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >10 gm/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 3,147,1969
TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 2 gm/kg
TOXIC EFFECTS :
Behavioral - ataxia
Lungs, Thorax, or Respiration - dyspnea
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 3,147,1969
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >1500 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 3,147,1969
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >500 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Behavioral - ataxia
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 3,147,1969
** OTHER MULTIPLE DOSE TOXICITY DATA **
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 11250 mg/kg/45D-C
TOXIC EFFECTS :
Gastrointestinal - other changes
Liver - changes in liver weight
Endocrine - changes in spleen weight
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 3,147,1969
*** END OF RECORD ***
|
|
|
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
| NAME | CAS |
Benzothiazole,5-methoxy-2-(beta-(1-pyrrolidinyl)-p-phenetidino)-
| 38519-94-7 |
Benzothiazole, 2-methyl-
| 120-75-2 |
Benzothiazole, 2-(methylamino)-
| 16954-69-1 |
Benzothiazole, 6-((p-(methylamino)phenyl)azo)-
| 16954-69-1 |
Benzothiazole,2-(2-((1-methylethyl)thio)-4-thiazolyl)-
| 67723-95-9 |
Benzothiazole, 2-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-
| 43193-11-9 |
Benzothiazole, 2-(3-methyl-1H-pyrazol-5-yl)-
| 43193-11-9 |
Benzothiazole, 2-(2-(methylthio)-4-thiazolyl)-
| 67723-92-6 |
Benzothiazole, 2-(morpholinothio)-
| 102-77-2 |
p-Benzoquinone,2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-
| 800-24-8 |
p-Benzoquinone, 2,6-dimethoxy-3-(hydroxymethyl)-,acetate (ester)
| 40870-53-9 |
Benzothiazole, 2-(4-morpholinyldithio)-
| 95-32-9 |
Benzothiazole, 6-nitro-2-(p-nitrobenzoylamino)-
| 64036-74-4 |
Benzothiazole, 2-(2-nitrophenyl)-
| 6269-45-0 |
Benzothiazole, 2-pentylthio-
| 73713-86-7 |
Benzothiazole, 2-phenyl-
| 883-93-2 |
Benzothiazole, 6-((p-piperidinophenyl)azo)-
| 84713-38-2 |
Benzothiazole, 2-(piperidinothio)-
| 26773-65-9 |
3(2H)-Benzothiazolepropanamide,2-imino-6-(trifluoromethoxy)-
| 130997-38-5 |
3(2H)-Benzothiazolepropanenitrile,2-imino-6-(trifluoromethoxy)-, ethanedioate (1:1)
| 130997-37-4 |
3-Benzothiazolepropanesulfonic acid,2-(4-(3-ethyl-4-oxo-2-thioxo-5-thiazolidinylidene)-2-butenylidene)-
| 64285-53-6 |
p-Benzoquinone,2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-
| 303-97-9 |
3(2H)-Benzothiazolepropanoic acid,2-(4-(3-(2-carboxyethyl)-4-oxo-2-thioxo-5-thiazolidinylidene)-2-butenylidene)-6-methyl-
| 62883-67-4 |
5-Benzothiazolepropionic acid, 2-phenyl-
| 52321-54-7 |
Benzothiazole, 2-(2-(propylthio)-4-thiazolyl)-
| 67723-94-8 |
Benzothiazole, 2-(2-pyridyl)-
| 716-80-3 |
Benzothiazole, 6-((p-(1-pyrrolidinyl)phenyl)azo)-
| 716-80-3 |
2-Benzothiazolesulfenamide
| 2801-21-0 |
2-Benzothiazolesulfenamide, N-tert-butyl-
| 95-31-8 |
2-Benzothiazolesulfenamide, N-cyclohexyl-
| 95-33-0 |
2-Benzothiazolesulfenamide, N,N-dicyclohexyl-
| 4979-32-2 |
2-Benzothiazolesulfenamide, N,N-diisopropyl-
| 95-29-4 |
p-Benzoquinone, 2,3-dimethyl-
| 526-86-3 |
2-Benzothiazolesulfonamide, 6-ethoxy-
| 452-35-7 |
Benzothiazolesulfonamide, N-(1-methylethyl)-
| 63904-87-0 |
7-Benzothiazolesulfonic acid,2-(p-aminophenyl)-6-methyl-
| 130-17-6 |
7-Benzothiazolesulfonic acid,2,2'-(1-triazene-1,3-diyldi-4,1-phenylene)bis(6-methyl-, disodium salt
| 1829-00-1 |
Benzothiazole, 4,5,6,7-tetrahydro-2-amino-
| 2933-29-1 |
Benzothiazole, 4,5,6,7-tetrahydro-,1,2-ethanedisulfonate (2:1)
| 31784-85-7 |
Benzothiazole, 4,5,6,7-tetrahydro-6-(methylamino)-
| 70590-58-8 |
Benzothiazole,4,5,6,7-tetrahydro-2-(2-(5-nitrofuryl)vinyl)-
| 30311-48-9 |
Benzothiazole,4,5,6,7-tetrahydro-2-(2-(5-nitrofuryl)vinyl)-,3-oxide
| 40019-78-1 |
2-Benzothiazolethiol
| 149-30-4 |
p-Benzoquinone, 2,5-dimethyl-
| 137-18-8 |
2-Benzothiazolethiol, 6-amino-
| 7442-07-1 |
2-Benzothiazolethiol, 5-chloro-
| 5331-91-9 |
2-Benzothiazolethiol, 6-ethoxy-
| 120-53-6 |
Benzothiazolethiol, 2-ethoxycarbonylmethyl-
| 64036-42-6 |
Benzothiazolethiol, 2-methyl-
| 64036-43-7 |
2-Benzothiazolethiol, 6-nitro-
| 4845-58-3 |
|
|